ZFPM2 and central nervous system cancer: In the present study, the hexamer insertion-deletion polymorphism rs71305152 was genotyped in glioma and control cohorts, as well as cohorts of non-glioma cancer in order to estimate the contribution of rs71305152 to cancer risk, especially for gliomas, and the evolutionary pressure acting on ZFPM2 was investigated.